Synonym/Acronym
N/A
Rationale
To provide a quick identification of gram-negative or gram-positive organisms to assist in medical management.
Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.
Normal Findings
N/A
Timely notification to the requesting health-care provider (HCP) of any critical findings and related symptoms is a role expectation of the professional nurse. A listing of these findings varies among facilities.
(Study type: Blood, biopsy specimen, or body fluid as collected for culture; related body system: ) .
Gram stain is a technique commonly used to identify bacterial organisms on the basis of their specific staining characteristics. The method involves smearing a small amount of specimen on a slide, and then exposing it to gentian or crystal violet, iodine, alcohol, and safranin O. Gram-positive bacteria retain the gentian or crystal violet and iodine stain complex after a decolorization step and appear purple-blue in color. Gram-negative bacteria do not retain the stain after decolorization but can pick up the pink color of the safranin O counterstain.
Gram stains provide information regarding the adequacy of a sample. For example, a sputum Gram stain showing greater than 25 squamous epithelial cells per low-power field, regardless of the number of polymorphonuclear white blood cells, indicates contamination of the specimen with saliva, and the specimen should be rejected for subsequent culture. Gram stains are reviewed over a number of fields for an impression of the quantity of organisms present, which reflects the extent of infection. For example, a Gram stain of unspun urine showing the occasional presence of bacteria per low-power field suggests a correlating colony count of 10,000 bacteria/mL, while the presence of bacteria in most fields is clinically significant and suggests greater than 100,000 bacteria/mL of urine. Gram stain results should be correlated with culture and sensitivity results to interpret the significance of isolated organisms and to select appropriate antibiotic therapy.
Gram Positive | ||||||||
---|---|---|---|---|---|---|---|---|
Actinomadura | Actinomyces | Bacillus | Clostridium, Clostridioides | Corynebacterium | ||||
Enterococcus | Erysipelothrix | Lactobacillus | Listeria | Micrococcus | ||||
Mycobacterium (gram variable) | Peptostreptococcus | Propionibacterium | Rhodococcus | Staphylococcus | ||||
Streptococcus |
Gram Negative | ||||||||
---|---|---|---|---|---|---|---|---|
Acinetobacter | Aeromonas | Alcaligenes | Bacteroides | Bordetella | ||||
Borrelia | Brucella | Campylobacter | Citrobacter | Chlamydia | ||||
Enterobacter | Escherichia | Flavobacterium | Francisella | Fusobacterium | ||||
Gardnerella | Haemophilus | Helicobacter | Klebsiella | Legionella | ||||
Leptospira | Moraxella | Neisseria | Pasteurella | Plesiomonas | ||||
Porphyromonas | Prevotella | Proteus | Pseudomonas | Rickettsia | ||||
Salmonella | Serratia | Shigella | Vibrio | Xanthomonas | ||||
Yersinia |
Acid Fast or Partial Acid Fast | ||
---|---|---|
Nocardia | Mycobacterium |
Note:Treponema species are classified as gram- negative spirochetes, but they are most often visualized using dark-field or silver-staining techniques.
Before the Study: Planning and Implementation
Teaching the Patient What to Expect
After the Study: Implementation & Evaluation Potential Nursing Actions
Treatment Considerations
Clinical Judgement
Follow-Up Evaluation and Desired Outcomes